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Background. Alterations in expression of hepatic genes that could contribute to resistance to dietary cholesterol were investigated
in Sprague-Dawley rats, which are known to be resistant to the serum cholesterol raising action of dietary cholesterol. Methods.
Microarray analysis was used to provide a comprehensive analysis of changes in hepatic gene expression in rats in response to
dietary cholesterol. Changes were confirmed by RT-PCR analysis. Western blotting was employed to measure changes in hepatic
cholesterol 7α hydroxylase protein. Results. Of the 28,000 genes examined using the Aﬀymetrix rat microarray, relatively few were
significantly altered. As expected, decreases were observed for several genes that encode enzymes of the cholesterol biosynthetic
pathway. The largest decreases were seen for squalene epoxidase and lanosterol 14α demethylase (CYP 51A1). These changes were
confirmed by quantitative RT-PCR. LDL receptor expression was not altered by dietary cholesterol. Critically, the expression of
cholesterol 7α hydroxylase, which catalyzes the rate-limiting step in bile acid synthesis, was increased over 4-fold in livers of rats fed
diets containing 1% cholesterol. In contrast, mice, which are not resistant to dietary cholesterol, exhibited lower hepatic cholesterol
7α hydroxylase (CYP7A1) protein levels, which were not increased in response to diets containing 2% cholesterol.

1. Introduction
There is considerable variation among animals and humans
in terms of their responses to consumption of excess dietary
cholesterol. Consumption of a high-cholesterol diet does not
automatically result in elevated serum cholesterol levels due
to the operation of adaptive responses. Rabbits, hamsters,
and C57BL/6 mice are not resistant to dietary cholesterol
and exhibit marked elevations in serum cholesterol levels
when given diets supplemented with cholesterol [1–3]. On
the other hand, rats such as Sprague-Dawley, Wistar-Furth,
Spontaneously Hypertensive or Fischer 344 show very little if
any increase in serum cholesterol levels when given a similar
cholesterol challenge [2]. For most humans, consumption of
increased amounts of dietary cholesterol produces only small
increases in both LDL and HDL cholesterol with little eﬀect
on the ratio of LDL to HDL [4, 5]. In a 14-year study of
over 80,000 female nurses, egg consumption was unrelated to
the risk of coronary heart disease [4]. On balance, extensive
epidemiologic studies show that dietary cholesterol is not
a contributor to increased heart disease risk in humans

[6]. Clearly, in many rat strains and most people, adaptive
responses are operating that keep serum cholesterol levels
within the normal range.
Multiple possible mechanisms may be operating to provide a person or animal with resistance to the serum cholesterol-raising action of dietary cholesterol. These include
decreasing the rate of cholesterol biosynthesis, decreasing the
rate of cholesterol absorption, increasing the rate of cholesterol excretion, increasing the conversion of cholesterol to
bile acids, and increasing the rate of removal of serum cholesterol via liver lipoprotein receptors [7, 8].
In order to obtain a comprehensive and unbiased analysis
of adaptive responses in hepatic gene expression to dietary
cholesterol, we carried out microarray analysis of changes in
Sprague-Dawley rat liver gene expression elicited by a 1%
cholesterol diet. These animals are known to have adaptive
responses that render them resistant to dietary cholesterol. In
order to induce atherosclerotic plaques in these animals, the
rats must be rendered hypothyroid [9]. Thus, this animal is a
reasonable model for human responses to dietary cholesterol.
In a previous microarray study, C57BL/6 mice were used
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[10]. These mice become hypercholesterolemic and develop
fatty lesions in their ascending aortas when given diets
supplemented with cholesterol [11, 12].
Liver was selected for extensive study, because this tissue
not only synthesizes cholesterol but also is also responsible
for bile acid production and excretion of cholesterol and
expresses the majority of the body’s LDL receptors [13].
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converted to double-stranded cDNA using an oligo(dT)24
primer containing a T7 RNA polymerase recognition sequence. The product was transcribed into biotin-labeled
cRNA using T7 RNA polymerase. The biotinylated cRNA was
hybridized to Aﬀymetrix GeneChip Rat Genome 230 Plus
2.0 arrays, which detects about 28,000 genes. Multiple oligos
were used for each gene with the data averaged. Scanned chip
images were analyzed using GeneChip algorithms.

2. Methods
2.1. Animals. Male Sprague-Dawley rats, 150–200 g (Harlan,
Madison, Wis, USA), were fed Harlan Teklad 22/5 rodent
chow with or without 1% cholesterol for five days. The
animals were kept in a reversed lighting cycle room (12
dark/12 hrs light) and sacrificed at 0900–1000 hrs, corresponding to the third to fourth hour of the dark period
when cholesterol biosynthesis is maximal. Twelve-week old
C57BL/6J mice were fed chow with or without 2% cholesterol
for 5 days. Liver samples were obtained, and microsomes
were prepared from both rats and mice [14]. All procedures
were carried out according to the regulations and oversight
of the University of South Florida Institutional Animal Care
and Use Committee (IACUC), protocol 2953.
2.2. Cholesterol Analysis. Trunk blood was collected and allowed to clot. The samples were centrifuged at 5,000 xg for
5 min. The serum was removed with a Pasteur pipette. Total
serum cholesterol levels were determined by a cholesterol
oxidase method using Infinity Cholesterol Reagent (Sigma)
[15]. Values are expressed as mg/dL of serum. Liver cholesterol levels were determined as previously described [16].
Briefly, weighed liver samples were saponified, extracted
with petroleum ether and subjected to reverse-phase highperformance liquid chromatography on a Spheri-5, RP18, 5 reverse-phase column (Altech Associates). Values are
expressed as mg/g of liver.
2.3. RNA Isolation. A portion of about 200 mg was quickly
excised from livers of the rats and immediately homogenized
in 4 mL of Tri-Reagent from Molecular Research Center
(Cincinnati, Ohio, USA) using a Polytron homogenizer at
room temperature. The remainder of the isolation steps was
carried out using volumes corresponding to 4x the manufacturer’s recommendations. RNA concentrations were determined by diluting each sample 1 : 100 and measuring its
absorbance at 260 nm.
2.4. Microarray Analysis . Isolated RNA was further purified
using the RNeasy kit from Qiagen. To demonstrate that the
RNA was indeed free of RNase activity, samples were incubated in water at 42◦ C for 1 hr and then examined on 1%
agarose gels. An identical pattern of bands in unheated and
heated samples was obtained showing a lack of RNase activity. Microarray analysis was performed by the Moﬃtt Core
Facility (Tampa, FL) using the Aﬀymetrix GeneChip Instrument system and the protocol established by Aﬀymetrix,
Inc. Ten μg of RNA each from the livers of 3 control and 3
cholesterol-fed rats was used in the analysis. The RNA was

2.5. Real Time RT-PCR Analysis. To validate the microarray
results, we assessed the expression of a subset of genes via
real-time PCR essentially as described previously [14]. Total
RNA was resuspended in diethyl pyrocarbonate-treated water. Twenty micrograms of RNA was then DNAse-treated
using the TURBO DNA-Free Kit from Ambion. cDNA was
prepared from 1 μg of DNAse-treated RNA using the Reverse
Transcription System from Promega. The final product was
brought up to 100 μL, and a total of 2 μL of the reverse
transcription reaction was then used for real-time PCR analysis. The primer sequences used are given in Table 1. PCR
was carried out according to the protocol from ABI Power
SYBR Green Master Mix, using a Chromo-4 DNA Engine
(Bio-Rad) with minor modifications. The program used for
amplification was (i) 95◦ C for 5 minutes, (ii) 95◦ C for 15 seconds, (iii) 61◦ C for 1 minute (collect data), and (iv) go to step
(ii) 40 times, (v) 55◦ C + 0.5◦ C each 10 seconds, ×80 (melt
curve). The results were quantified by the ΔΔCt method
using Microsoft Excel statistical programs and SigmaPlot
8.0. As a housekeeping gene, 18S ribosomal RNA was used.
Values are expressed relative to this.
2.6. Western Blot Analysis. At time of sacrifice, a portion of
liver was excised for protein analysis. Lysosome-free liver
microsomes were prepared according to the procedure previously described [17]. Liver microsomes (50 μg of protein
per lane) from rats and mice were subjected to SDS-PAGE
and western blotting. Membranes were incubated overnight
with 1 : 2,000 dilution of cholesterol 7α hydroxylase primary
antibody generated in rabbits and generously provided to us
by Dr. Mats Rudling in 5% PBST nonfat dry milk. A 1 : 10,000
dilution of Sheep anti Rabbit IGG was as the secondary
antibody. The West Pico Chemiluminesence kit was used for
detection with exposure times ranging from 5 to 20 seconds.
The blots were then stripped and reprobed with an antibody
to β-actin. The resulted were expressed relative to the β-actin
signal.
2.7. Statistics. For the microarray data, a 2-tailed distribution
t-test, equal variance was used. The RT-PCR data are presented as means ± standard errors. P values using a 2-tailed
distribution t-test are given.

3. Results
3.1. Microarray Analysis. In order to comprehensively identify the genes that exhibit significant alterations in rates of
transcription in response to dietary cholesterol, microarray
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Table 1: Oligonucleotide sequences used for RT-PCR analysis.
Gene
SQLE
CYP51
ABCG8
ABCG5
ACAT2
CYP7A
7DHCR
D14SR
HMGCR
HMGCS
IGFBP1
LANS
LIPIN2
PPARα
PPARγ
SC4MEOX

Primers
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense

Sequence (5 → 3 )
AGTGAACAAACGAGGCGTCCTACT
AAAGCGACTGTCATTCCTCCACCA
TTAGGTGACAACCTGACACACGCT
TGCTTACTGTCTTGCTCCTGGTGT
GATGCTGGCTATCATAGGGAGC
TCTCTGCCTGTGATAACGTCGA
TGAGCTCTTCCACCACTTCGACAA
TGTCCACCGATGTCAAGTCCATGT
TTGTGCCAGTGCACGTGTCTTCTA
GCTTCAGCTTGCTCATGGCTTCAA
TGAAAGCGGGAAAGCAAAGACCAC
TCTTGGACGGCAAAGAGTCTTCCA
TCAGCTTCCAGGTGCTGCTTTACT
ACAATCCCTGCTGGAGTTATGGCA
AATGGTTTCCAGGCTCTGGTGCTA
ATAAAGCTGGTGAGAGTGGTCGCA
ATTGCACCGACAAGAAACCTGCTG
TTCTCTCACCACCTTGGCTGGAAT
TTGGTAGTTGCAGGAGACATCGCT
AGCATTTGGCCCAATTAGCAGAGC
AGAGGAACAGCTGCTGGATAGCTT
AGGGCTCCTTCCATTTCTTGAGGT
ACTCTACGATGCTGTGGCTGTGTT
AAATACCCGCCACGCTTAGTCTCA
TCTGCCATGGACTTGCCTGATGTA
ACTCGTGGTACGTGATGATGTGCT
AGACCTTGTGCATGGCTGAGAAGA
AATCGGACCTCTGCCTCCTTGTTT
CAATGCCATCAGGTTTGGGCGAAT
ATACAAATGCTTTGCCAGGGCTCG
ACCTGGCACTATTTCCTGCACAGA
AGCCTGGAACTCGTGATGGACTTC

Table 2: Serum and liver cholesterol levels.
Condition
Normal
Cholesterol fed

Serum
Mg/100 mL
128 ± 5
102 ± 4

Liver
Mg/g
3.2 ± 0.3
6.2 ± 0.5∗

∗

P < 0.01 compared with normal chow fed rats. A 2-tailed distribution ttest, equal variance was used.

analysis was performed on hepatic RNA from SpragueDawley rats fed either normal rodent chow or chow supplemented with 1% cholesterol for 5 days. This dietary regimen
does not raise serum cholesterol levels in these male Sprague
Dawley rats [2, 18]. Liver cholesterol levels are increased
about 2-fold (Table 2). This is similar to our previous findings with 2% cholesterol [16]. Thus, this treatment appears
to constitute a useful model for studying adaptive responses.

Surprisingly, the rates of transcription of relatively few
genes were altered more than 2-fold (Table 3). The largest increase was observed for insulin-like growth factor-binding
protein 1. This increase of over 4-fold was confirmed by
RT-PCR analysis (Table 5). A prominent increase of nearly
3-fold in hepatic cholesterol 7α hydroxylase expression was
observed. This would provide for increased production of
bile acids and more eﬃcient elimination of biliary cholesterol, since this enzyme catalyzes the rate-limiting step of bile
acid synthesis. ABCG5 and ABCG8 expression was actually decreased (Table 4). These ATP-binding cassette (ABC)
transport proteins promote biliary secretion of neutral sterols [19]. Also, acetyl CoA acetyltransferase 2 (ACAT2), which
esterifies excess cholesterol, was significantly decreased.
Strikingly, there was no change in hepatic LDL receptor expression.
Many of the genes exhibiting downregulated expression
in response to dietary cholesterol (Table 3) catalyze reactions
of the cholesterol biosynthetic pathway. Levels of mRNA for
the enzyme that catalyzes the rate-limiting reaction, HMGCoA reductase, were only decreased 2-fold. RT-PCR analysis
(Table 4) showed only a 1.4-fold decrease HMG-CoA reductase, in agreement with previous results from Northern
blotting analysis [20]. The largest decrease (7.9-fold) was
observed for squalene epoxidase. This enzyme regulates lanosterol synthesis [21]. The next largest decrease among cholesterol biosynthetic enzymes was seen for lanosterol 14α demethylase. The expression of several cholesterol biosynthetic
enzymes including Δ14 sterol reductase, sterol C4 methyl
oxidase-like, 7-dehydrocholesterol reductase, HMG-CoA
synthase 1, farnesyl diphosphate synthase, lanosterol synthase, acetoacetyl CoA synthase, and mevalonate kinase were
decreased 2 to 4-fold (Table 4). Other cholesterol biosynthetic enzymes such as sterol-C5-desaturase, phosphomevalonate kinase, diphosphomevalonate decarboxylase, 24-dehydrocholesterol reductase and dehydrogenase/reductase (SDR
family) member 7 were decreased 1.5- to 1.9-fold. Other
genes of interest whose expression was decreased by dietary
cholesterol were SREBP-2 (1.4-fold, P = 0.028) and PCSK9
(1.5-fold, P = 0.022).
3.2. RT-PCR Analysis. Quantitative RT-PCR was utilized to
examine a subset of the altered genes that were identified
via microarray analysis. The results are presented in Table 5
and correlate with those seen in the microarray analysis. For
example, the expression of squalene epoxidase (Sqle) and
lanosterol 14α demethylase (Cyp51A1) were decreased by
8.29 and 4.53-fold, respectively (Table 5) as compared with
7.9 and 3.5-fold in the microarray analysis (Table 4). The
relative fold changes in ABCG5 and 8, HMG-CoA synthase,
ACAT-2, lanosterol synthase, sterol C4 methyl oxidase-like,
lipin 2, cholesterol 7α hydroxylase, and 7-dehydrocholesterol
reductase also agree very closely, providing further verification of the data obtained from the microarray analysis.
3.3. Western Blotting Analysis. Since the increase in rat liver
cholesterol 7α hydroxylase mRNA caused by dietary cholesterol could be important for the elimination of cholesterol
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Table 3: Microarray analysis identifying genes upregulated by dietary cholesterol.
Normal

386
476
3597
73
2287
127
253
34
207
4255
∗

507
457
5311
304
1733
387
372
131
684
2830

Cholesterol
439
536
8493
546
1841
320
250
263
856
4209

2377
2322
16287
853
5590
756
766
332
1358
9654

1264
2418
17914
747
5726
494
759
303
1006
4959

2347
988
12394
746
5166
773
536
344
1277
8308

Fold diﬀ
+4.5∗∗
+3.9∗
+2.7∗∗
+2.5∗
+2.8∗∗
+2.4∗
+2.4∗∗
+2.3∗
+2.1∗
+2.0

Gene
Insulin-like growth factor binding protein 1
B-cell leukemia/lymphoma 6 (predicted)
Cholesterol 7α hydroxylase
Similar to Ran-binding protein 2 (predicted)
Zinc finger protein 354A
PPARα
Lipin 2 (predicted)
Zinc finger, matrin-like (predicted)
HGPRTase
Glucose-6-phosphatase

P < 0.05; ∗∗ P < 0.01. A 2-tailed distribution t-test, equal variance was used.

Table 4: Microarray analysis identifying genes downregulated by dietary cholesterol.
Normal
1185
588
574
2353
10377
3890
1049
238
733
1998
11250
6083
2851
14079
14890
1857
4946
1695
13476
10599
444
1269
10087
2516
848
∗

2381
783
373
3066
11676
4874
893
316
1023
608
14322
6326
2771
17666
13208
2636
5502
2518
13702
8161
591
1465
11135
2177
1080

Cholesterol
1598
426
195
2285
10752
3668
1196
242
760
524
9729
4997
2112
16412
12147
1792
4267
1567
14018
6620
470
1136
8727
2744
873

219
148
51
735
2690
929
186
65
233
340
3511
1961
1027
5555
5146
882
1503
870
6048
3050
225
604
4223
1138
538

232
84
144
783
3350
1280
216
115
232
343
4636
2597
879
6296
5920
1025
2456
834
7357
4215
288
749
5304
1049
444

203
143
62
503
3329
1426
542
76
345
375
4315
2103
1055
7154
5178
635
1667
814
5541
4797
205
548
5287
1509
432

Fold diﬀ
−7.9∗∗
−4.8∗∗
−4.5
−3.8∗
−3.5∗∗
−3.4∗∗
−3.3∗∗
−3.1∗∗
−3.1∗∗
−3.0
−2.8∗∗
−2.6∗∗
−2.6∗∗
−2.5∗∗
−2.5∗∗
−2.5∗∗
−2.6∗∗
−2.3∗
−2.2∗∗
−2.1∗
−2.1∗∗
−2.0∗∗
−2.0∗∗
−2.0∗∗
−2.0∗∗

Gene
Squalene epoxidase
ABCG8
Hypo protein XP 580018
Acetyl CoA Acetyltransferase2
Lanosterol 14α demethylase
Delta 14 sterol reductase
Cytokine inducible SH2 protein
Nuc factor, erythroid derived 2
Ephrin A5
Dual specificity phosphatase1
Sterol C4 methyl oxidase-like
7-Dehydrocholesterol reductase
Solute carrier family 25 mem 30
HMG-CoA Synthase 1
Farnesyl diphosphate synthase
Lanosterol synthase
Farnesyl diphos transferase 1
ABCG5
Fatty acid desaturase 1
Hemato expressed homeobox
Acetoacetyl CoA synthase
Hypo protein XP 579849
HMGCR
Forkhead box A2
Mevalonate kinase

P < 0.05; ∗∗ P < 0.01. A 2-tailed distribution t-test, equal variance was used.

from the body, we wished to determine whether levels of
this protein are actually increased. For comparison purposes,
we examined the eﬀect of dietary cholesterol on mouse
liver cholesterol 7α hydroxylase protein. Cholesterol 7α
hydroxylase protein levels were much higher in rat liver than
in mouse liver (Figure 1). Supplementing the chow with
1% cholesterol increased hepatic cholesterol 7α hydroxylase
protein levels in rats from 1.22 ± 0.78 to 6.52 ± 2.27

(4 chow-fed rats compared with 5 cholesterol-fed animals
with a P = 0.011). In contrast, little eﬀect on the levels in
mouse liver was seen even when 2% cholesterol was added to
the diet (Figure 1).
3.4. Time-Course Experiment. A time-course experiment was
conducted to determine how rapidly dietary cholesterol
reduces the expression of Sqle and Cyp51. RT-PCR analysis,
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Table 5: RT-PCR analysis.

Gene
ABCG5
ABCG8
HMG-CoA synthase
Squalene epoxidase
Lanosterol 14α demeth
Delta 14 sterol reductase
Lanosterol synthase
ACAT-2
Sterol C4 Me Ox like
7-Dehydrocholesterol red
HMG-CoA reductase
PPAR gamma
PPAR alpha
Lipin 2 (predicted)
Chol 7α hydroxylase
IGFBP1

Normal
1.00 ± 0.07
1.02 ± 0.17
1.03 ± 0.23
1.17 ± 0.26
0.71 ± 0.28
1.03 ± 0.31
1.12 ± 0.58
1.00 ± 0.08
1.04 ± 0.31
1.01 ± 0.13
1.02 ± 0.26
1.07 ± 0.40
1.01 ± 0.18
1.03 ± 0.29
1.17 ± 0.35
1.02 ± 0.31

Cholesterol
0.67 ± 0.09
0.17 ± 0.03
0.23 ± 0.01
0.14 ± 0.03
0.16 ± 0.01
0.19 ± 0.15
0.33 ± 0.14
0.31 ± 0.07
0.39 ± 0.50
0.50 ± 0.06
0.73 ± 0.28
1.02 ± 0.89
1.06 ± 0.44
1.64 ± 0.42
3.27 ± 0.97
4.30 ± 1.90

P value
0.018
0.003
0.008
0.002
0.027
0.013
0.083
0.001
0.128
0.004
0.261
0.944
0.852
0.105
0.044
0.042

Fold
−1.49
−6.00
−4.48
−8.29
−4.53
−5.33
−3.39
−3.20
−2.65
−2.00
−1.40
−1.04
+1.05
+1.59
+2.79
+4.22

A 2-tailed distribution t-test, equal variance was used.

C (R)

N (M)

C (M)

1.4

150
100
75
50
37

CYP7A1

Figure 1: Comparison of the eﬀects of dietary cholesterol on
hepatic cholesterol 7α hydroxylase protein levels in rats and Mice.
Rats (R) and mice (M) were fed normal (N) chow diets with or
without 1% or 2% cholesterol (C) for 5 days. A representative Western blot of hepatic microsomal cholesterol 7α hydroxylase protein
is presented.

Relative Sqle mRNA expression

N (R)

1.2
1
0.8
∗

0.6

∗

0.4

∗∗

0.2
0
0

1

2

3

Days

as shown in Figures 2 and 3, demonstrates that the decrease
in Sqle occurred more rapidly. Both Sqle and Cyp51 decreased progressively over a 3-day period. This agrees with
the time course for the reduction in translation of HMGCoA reductase mRNA [22].

Figure 2: Eﬀect of cholesterol feeding on hepatic squalene epoxidase mRNA levels. Rats were fed a diet containing 1% cholesterol
for the indicated number of days. Hepatic mRNA levels were
determined by RT-PCR. Values are given as means ± Standard Error
for 3 to 6 rats per time point. ∗ P < 0.05; ∗∗ P < 0.01.

4. Conclusion
Sprague Dawley rats from Harlan fed the grain-based Tekland 22/5 rodent chow diet resist a high cholesterol dietinduced increase in serum cholesterol as reported previously
[2, 16]. They do show increases in liver cholesterol levels
(Table 2). This indicates that dietary cholesterol is eﬀectively
taken up by the intestine, where Niemann-Pick C1-like 1
protein facilitates its uptake [23]. The resulting chylomicron
remanents are taken up by the liver. With the increased
cholesterol from the diet, the activity of the hepatic LDL
receptor, as determined from its rate of turnover, is markedly
decreased [18]. Thus, the cycling of this receptor, located
in the cholesterol-rich caveolae portion of the plasma

membrane [24], virtually stops [18]. The levels of hepatic
LDL receptor protein and mRNA do not, however, change
[18]. Since the liver must play a key role in adapting to and
resisting the increase load of cholesterol, we conducted a
microarray study to investigate changes in hepatic mRNA
levels.
Of all the hepatic genes examined, the most dramatic
changes seen in response to dietary cholesterol were the decreases in Sqle and Cyp51. These changes seen in the microarray experiment were confirmed by RT-PCR. When lanosterol levels are decreased as occurs when Sqle expression is
decreased, the diﬀerent Kms of the three reactions catalyzed
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Relative CYP51A1 mRNA expression

6

0.8

0.6
∗

0.4

∗∗

0.2

0
0

1

2

3

Days

Figure 3: Eﬀect of cholesterol feeding on hepatic lanosterol 14α
demethylase mRNA levels. Rats were fed a diet containing 1%
cholesterol for the indicated number of days. Hepatic mRNA levels
were determined by RT-PCR. Values are given as means ± Standard
Error for 3 to 6 rats per time point. ∗ P < 0.05; ∗∗ P < 0.01.

by Cyp51 come into play. The Km for the formation of 3βhydroxylanosterol-8-en-32-al is 56 μM while the Km for its
destruction (conversion to 4 dimethylcholesta 8, 14 dien3β-ol) is 368 μM [25]. Although there would be suﬃcient
lanosterol for the first reaction catalyzed by CYP51 (formation of 3β-hydroxylanosterol-8-en-32-al), because of the
low Km, its subsequent conversion to 4 dimethylcholesta
8, 14 dien-3β-ol would be slow due to the high Km for
this reaction. Thus, 3β-hydroxylanosterol-8-en-32-al would
accumulate. This oxylanosterol is known to act to decrease
the rate of translation of hepatic HMG-CoA reductase in
CHO cells [26]. The structural analogue, 15α-fluoro-3βhydroxylanost-7-en-32-aldehyde has also been reported to
inhibit translation of HMG-CoA reductase mRNA in CHO
cells [27]. In addition, it has been demonstrated that feeding
the nonmetabolizable oxylanosterol analogue, 15 oxa-32vinyllanost-8-ene-3β, 32 diol to rats results in a marked decrease in translation of hepatic HMG-CoA reductase mRNA
which mimics the eﬀect of dietary cholesterol [28]. Thus,
dietary cholesterol-mediated decreases in Sqle and Cyp51
transcription lead to decreased translation of hepatic HMGCoA reductase mRNA.
In this microarray study, a 2-fold decrease in HMG-CoA
reductase expression was observed in response to dietary
cholesterol. The SREs in the promoters of both Sqle and
Cyp51 [29, 30] have been shown to be responsive to SREBP2
and would be expected to be downregulated by cholesterol
feeding. However, the SRE sequence in the HMG-CoA reductase promoter does not agree well with the consensus SRE,
which may explain the only modest decrease in HMG-CoA
reductase transcription in response to dietary cholesterol.
Previous Northern blotting analysis and nuclear run-on
studies showed only slight decreases in mRNA levels and
rates of transcription for hepatic HMG-CoA reductase [20,
31]. However, enzyme activity and protein levels drop to
a couple percent of control values [20, 31]. This is due

primarily to a marked decrease in the rate of translation of
HMG-CoA reductase mRNA caused by feeding cholesterol
[22]. The decrease in the rate of translation of HMG-CoA
reductase mRNA is due to shift from association of the
mRNA with polysomes to monosomes caused by dietary
cholesterol [32]. The present observations are predicted by
the proposed two-step model for feedback regulation of
hepatic HMG-CoA reductase gene expression [33]. In this
model, increased hepatic cholesterol leads to decreased
formation of mature SREBP2 and decreased transcription of
Sqle and Cyp51. This in turn results in accumulation of 3βhydroxylanosterol-8-en-32-al, which acts to decrease translation of hepatic HMG-CoA reductase mRNA [20].
In addition to adapting to excess dietary cholesterol
by decreasing the rate of hepatic cholesterol biosynthesis,
adaptations in bile acid pathways also occurred. A 2.7-fold
increase was observed in cholesterol 7α hydroxylase expression, which is the enzyme that catalyzes the rate-limiting step
in bile acid synthesis (Table 3). We have previously observed
by Northern blotting analysis that hepatic cholesterol 7α
hydroxylase mRNA is markedly increased in rats [16]. Paradoxically, the microarray analysis did not show increases in
expression of the ABCG5/G8 transporters. Instead, decreases
in the expression of both ABCG5 and ABCG8 were observed.
The expression of ABCG8, in particular, was markedly
decreased. These findings were confirmed by RT-PCR analysis (Table 4). This is in contrast to the study in mice where
ABCG5 expression was reported to be upregulated about 2fold in response to dietary cholesterol [10]. In agreement
with previous Northern blotting analysis, cholesterol feeding
did not aﬀect hepatic LDL receptor mRNA levels [18].
However, the rate of cycling and hence activity of the receptor
is markedly decreased in response to dietary cholesterol [18].
Western blotting analysis showed that dietary cholesterol
increases hepatic cholesterol 7α hydroxylase protein levels in
rats but not in mice (Figure 1). Also, mice exhibited lower
levels of cholesterol 7α hydroxylase protein in their livers.
This is in agreement with a previous study [34] showing
that dietary cholesterol caused a 3-fold increase in hepatic
cholesterol 7α hydroxylase mRNA in rats with much less
eﬀect in C57BL/6J mice. Other reports showed that dietary
cholesterol may act to increase or decrease cholesterol 7α
hydroxylase mRNA levels in C57BL/6J mice depending on
the type of fat added to the diet [35, 36]. Diets supplemented with olive oil (monounsaturated fatty acids) caused
increased expression of hepatic cholesterol 7α hydroxylase.
Western blotting analysis of cholesterol 7α hydroxylase was
not preformed in these previous studies.
In a recent study comparing the responses of hamsters
and rats to cholesterol-enriched diets, it was found that
hepatic cholesterol 7α hydroxylase expression in hamsters
was not increased in response to cholesterol feeding [37].
This is in contrast with the increase seen in rats. However,
hamsters do not adapt well to cholesterol supplemented
diets, as their serum cholesterol levels are increased about 2fold in response to a 0.1% cholesterol diet [37]. Also, hamsters express much lower (only 2 percent of that of rats) basal
levels of hepatic HMG-CoA reductase [2], which renders
them less able to resist the eﬀects of dietary cholesterol [13].
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The eﬀect of a high cholesterol diet on the expression of
genes in livers of mice has been previously investigated by
microarray analysis [10]. In that study, Sqle was found to be
downregulated 3.4 and 2.8-fold in males and females, respectively. This correlates with the decrease (7.9-fold) observed
for hepatic Sqle expression in the present study. Apparently,
no changes in CYP51 or cholesterol 7α hydroxylase expression were observed in the previous study [10]. HMG-CoA
reductase was decreased 2-fold in males with no eﬀect seen
in females [10]. The greatest change in the previous study
was observed for a disintegrin and metalloprotease domain
11 family member (Adam 11) which was upregulated 5 to
11-fold in the microarray and TaqMan analysis. ADAM 11 is
a specific aggrecanase induced by interleukin 6 [38] which
would promote an inflammatory response. In the present
analysis, no change in Adam 11 expression was observed.
A significant increase in serum amyloid A3, an acute phase
reactant, was also observed in the earlier study [10]. An
increase in this protein also indicates an inflammatory response to a high cholesterol diet.
The largest cholesterol-induced increase in hepatic gene
expression in the present study was observed for insulinlike growth factor-binding protein 1 (IGFBP1), which was
measured at over 4-fold by both microarray and RT-PCR
analysis. This protein is produced by the liver during
inflammation [39], possibly caused by dietary cholesterol.
Increased levels are associated with an elevated risk of cardiovascular disease in type 2 diabetic patients [40]. IGFBP1 may
also be a marker for insulin resistance [41] and be involved in
the development of type 2 diabetes [42]. It may be protective
against the growth of certain cancers by binding insulin-like
growth factor-1, a potent mitogen [43].
In summary, a comprehensive examination of the adaptive hepatic transcriptional responses to dietary cholesterol
was conducted using microarray and RT-PCR analysis. The
data suggest that rats adapt, in part, to excess dietary cholesterol by markedly reducing hepatic cholesterol biosynthesis
and enhancing elimination of cholesterol as bile acids due
to induction of cholesterol 7α hydroxylase. A large increase
in insulin-like growth factor-binding protein 1 was also
observed. This could partially explain the inflammatory response associated with excess dietary cholesterol.
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Rydén, and K. Brismar, “IGF binding protein 1 predicts
cardiovascular morbidity and mortality in patients with acute
myocardial infarction and type 2 diabetes,” Diabetes Care, vol.
30, no. 9, pp. 2343–2348, 2007.
[41] A. Borai, C. Livingstone, and G. A. A. Ferns, “The biochemical
assessment of insulin resistance,” Annals of Clinical Biochemistry, vol. 44, no. 4, pp. 324–342, 2007.
[42] F. Zhang, K. Sjoholm, and Q. Zhang, “Attenuation of insulin
secretion by insulin-like growth factor binding protein-1 in
pancreatic beta-cells,” Biochemical and Biophysical Research
Communications, vol. 362, pp. 152–157, 2007.
[43] B. M. Wolpin, D. S. Michaud, E. L. Giovannucci et al., “Circulating insulin-like growth factor binding protein-1 and the
risk of pancreatic cancer,” Cancer Research, vol. 67, no. 16, pp.
7923–7928, 2007.

9

International Journal of

Peptides

BioMed
Research International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Advances in

Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Virolog y
Hindawi Publishing Corporation
http://www.hindawi.com

International Journal of

Genomics

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Nucleic Acids

Zoology

International Journal of

Hindawi Publishing Corporation
http://www.hindawi.com

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Submit your manuscripts at
http://www.hindawi.com
The Scientific
World Journal

Journal of

Signal Transduction
Hindawi Publishing Corporation
http://www.hindawi.com

Genetics
Research International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Anatomy
Research International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Enzyme
Research

Archaea
Hindawi Publishing Corporation
http://www.hindawi.com

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Biochemistry
Research International

International Journal of

Microbiology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

International Journal of

Evolutionary Biology
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Molecular Biology
International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Advances in

Bioinformatics
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Marine Biology
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

